Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus aspirin for uteroplacental circulation in pregnant women with polycystic ovary syndrome
IRCT138812123485N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin and aspirin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Effect on uteroplacental circulation. Started Sep 2008; status: completed.
02
Drugs
metforminaspirin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT138812123485N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138812123485N1.